Jul 6 at 05:55 AM
$Eli Lilly(LLY.US) | πππ§ππ¨π« π π’ππ³π ππ«ππ₯π maintains ππ―ππ«π°ππ’π π‘π on ππ₯π’ ππ’π₯π₯π², π«ππ’π¬ππ¬ ππ ππ¨ $ππππ
Analyst sees strong 2Q26 biopharma results and guidance raises providing a fundamentals-driven tailwind to support outperformers like LLY.The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
